Skip to content
Screener

Conduit Pharmaceuticals CDT Q1 2026 Annual earnings

Reported July 15, 2026 · Before market open

Revenue$696.4M
EPS-$5.56

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$750.2M
Q1 2026$696.4M

Diluted EPS

Q2 2026-$8.71
Q1 2026-$5.56
Q4 2025-$99.99Q3 2025-$13.16Q2 2025-$43.68Q1 2025-$158.32

FAQ

When did Conduit Pharmaceuticals report Q1 2026 earnings?
Conduit Pharmaceuticals (CDT) reported Q1 2026 earnings on July 15, 2026 before market open.
What were Conduit Pharmaceuticals's Q1 2026 revenue and EPS?
Conduit Pharmaceuticals reported revenue of $696.4M and eps of $-5.56 for Q1 2026.
How did Conduit Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 96.5% from $-158.32.
Where can I find Conduit Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-033455) and the 10-K periodic report (0001493152-26-016858) directly on SEC EDGAR. The filing index links above go to sec.gov.